Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial
National Cancer Institute (NCI)
Stephanie Lheureux; Mihaela C Cristea; Jeffrey P Bruce; Swati Garg; Michael Cabanero; Gina Mantia-Smaldone; Alexander B Olawaiye; Susan L Ellard; Johanne I Weberpals; Andrea E Wahner Hendrickson; Gini F Fleming; Stephen Welch; Neesha C Dhani; Tracy Stockley; Prisni Rath; Katherine Karakasis; Gemma N Jones; Suzanne Jenkins; Jaime Rodriguez-Canales; Michael Tracy; Qian Tan; Valerie Bowering; Smitha Udagani; Lisa Wang; Charles A Kunos; Eric Chen; Trevor J Pugh; Amit M Oza